Amicus Therapeutics Inc (NASDAQ:FOLD) announced additional positive data on an important cardiac endpoint from its first Phase 3 study (Study 011) and the Phase 3 extension (Study 041) of the oral small molecule chaperone migalastat HCl (“migalastat”) for Fabry disease. Amicus Therapeutics, Inc. (NASDAQ:FOLD) in last trading activity increased 7.38% to close at $9.17. Company weekly performance is 10.22% while its quarterly performance stands at 38.94%. Amicus Therapeutics, Inc. (NASDAQ:FOLD) is 0.77% away from its 52 week high.
Intel Corporation (NASDAQ:INTC) has set a target to diversify its workforce by 2020 for increased efficiency, greater ideas, and a more global mindset. The announcement was made by Intel CEO, Brian Krzanich, at the Consumer Electronics Show (CES) 2015. On last trading day Intel Corporation (NASDAQ:INTC) increased 1.86% to close at $36.69. Its volatility for the week is 2.28% while volatility for the month is 1.94%. INTC’s sales growth for past 5 years was 7.00% and its EPS growth for past 5 years was 15.50%. Intel Corporation (NASDAQ:INTC) monthly performance is -1.37%.
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) reported that it has concluded consultations by means of U.S. and European health establishment regarding the design of a randomized, dose-ranging examination to assess three starting doses of Iclusig (ponatinib) in patients with refractory, chronic-phase chronic myeloid leukemia (CP-CML). On Thursday shares of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) closed at $7.02. Company’s sales growth for last 5 years was 45.10% and EPS growth for next 5 years is recorded as 41.40%.
Healthcare Realty Trust Incorporated (NYSE:HR) has seen some short covering recently. Short interest has registered a change of -0.2% in the past 1 month. The 3-month %change in short interest is -5.45%. The company has a short ratio of 3.72. On Thursday shares of Healthcare Realty Trust Incorporated (NYSE:HR) closed at $28.43. Company’s sales growth for last 5 years was 10.30% and EPS growth for next 5 years is recorded as 4.00%.
KeyCorp cut shares of HB Fuller (NYSE:FUL) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning, TheFlyOnTheWall.com reports. The analysts noted that the move was a valuation call. On last trading day HB Fuller Co. (NYSE:FUL) increased 2.07% to close at $41.85. Its volatility for the week is 2.52% while volatility for the month is 2.34%. FUL’s sales growth for past 5 years was 8.00% and its EPS growth for past 5 years was 39.00%. HB Fuller Co. (NYSE:FUL) monthly performance is -6.08%.